FDA Inspection
Shandong New Time Pharmaceutical Co. Ltd.Shandong New Time Pharmaceutical Co. Ltd. – FDA Inspection, May 11, 2018
Record Details
This FDA Inspection record concerns Shandong New Time Pharmaceutical Co. Ltd., with an inspection on May 11, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 52a2304e-d72c-4c91-9a20-7a87b78b52fc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1054213
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Shandong New Time Pharmaceutical Co. Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 9, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 25, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shandong New Time Pharmaceutical Co. Ltd.
- FDA Inspection 1244268 - 2024-07-09
- FDA Inspection 967561 - 2016-03-25
- FDA Inspection 854834 - 2013-08-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.